Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.34 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12299094 | 0.96 | SIGMAR1 (0.40) | CYP1A2CYP2D6SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL12299154 | 0.95 | SIGMAR1 (0.41) | CYP1A2CYP2D6SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL12299107 | 0.94 | CYP1A2 (0.40) | CYP1A2CYP2D6SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL12299125 | 0.93 | CYP1A2 (0.39) | CYP1A2CYP2D6SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL12299092 | 0.93 | CYP1A2 (0.36) | CYP1A2CYP2D6SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL13027991 | 0.92 | SIGMAR1 (0.38) | CYP1A2CYP2D6SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL13351437 | 0.92 | SIGMAR1 (0.38) | CYP1A2CYP2D6SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL13027951 | 0.92 | SIGMAR1 (0.38) | CYP1A2CYP2D6SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL12299098 | 0.91 | CYP1A2 (0.37) | CYP1A2CYP2D6SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL12299108 | 0.91 | CYP1A2 (0.41) | CYP1A2CYP2D6SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8986854-B2 | Composite material, material for light-emitting element, light-emitting element, light-emitting device and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
| US-20110227051-A1 | COMPOSITE MATERIAL, MATERIAL FOR LIGHT-EMITTING ELEMENT, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-09-22 | — | — | US | disclosed |
| US-7977865-B2 | Composite material, material for light-emitting element, light-emitting element, light-emitting device and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20090072714-A1 | Composite Material, Material for Light-Emitting Element, Light-Emitting Element, Light-Emitting Device and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-03-19 | — | — | US | disclosed |
| US-20080154005-A1 | Hole-Injecting Material, Material for Light-Emitting Element, Light-Emitting Element, Organic Compound, Monomer, and Monomer Mixture | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080154005-A1 | Hole-Injecting Material, Material for Light-Emitting Element, Light-Emitting Element, Organic Compound, Monomer, and Monomer Mixture | OPRM1, ELMO1, ACVRL1 | CYP1A2 1407/4885CYP2D6 2705/4885SIGMAR1 1121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.